71Indexed trials
Market Rank #28 · Evidence Tier A
Greece
Neuroscience Intelligence
Greece neuroscience intelligence: 71 indexed trials, 52 institutions, research score 34.76.
31Recruiting
52Research institutions
34.8Research score
Evidence profile
43Sponsors
19Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 34.8 · Data confidence 100.00 · Evidence 34.8
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons12trials
alzheimers11trials
epilepsy9trials
multiple_sclerosis7trials
schizophrenia6trials
stroke5trials
depression3trials
adhd2trials
neuro_oncology2trials
neuromuscular2trials
Leading indexed sponsors
Merck Sharp & Dohme LLC10trials
Aristotle University Of Thessaloniki5trials
Boehringer Ingelheim4trials
Hoffmann-La Roche3trials
Attikon Hospital2trials
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2trials
GlaxoSmithKline2trials
Bristol-Myers Squibb2trials
Eli Lilly and Company2trials
National and Kapodistrian University of Athens2trials